Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL)

Peter Pickkers(Radboud University Nijmegen), Derek C. Angus(MACOM (United States)), Erik van den Berg(AM–Pharma (Netherlands)), Isabelle Michaux(Centre Hospitalier Universitaire de Liège), Vincent Huberlant(Centre Hospitalier Universitaire de Nantes), Rinaldo Bellomo(Monash University), Ville Pettilä, Henrik Gammelager(Aarhus University Hospital), Alexander Zarbock(Outcomes Research Consortium), John A. Kellum(University of Pittsburgh), Kent Doi(The University of Tokyo), Michael Joannidis(Innsbruck Medical University), Ludovic Gérard(Cliniques Universitaires Saint-Luc), Thomas Strøm(University of Southern Denmark), Ricard Ferrer(Universitat Autònoma de Barcelona), Angus Carter, Paul J. Young(Wellington Hospital), Alistair Nichol(University College Dublin), Christopher J. Doig, Christoffer Sølling(Aalborg University), Morten H. Bestle(University of Copenhagen), Juliane Bernholz(AM–Pharma (Netherlands)), D Friès, Tom Fivez(Ziekenhuis Oost-Limburg), Kathleen D. Liu(University of California San Diego Medical Center), Alexis F. Turgeon(Université Laval), Philip Eller, Marlies Ostermann(St Thomas' Hospital), Scott J. Millington(University of Ottawa), Eric A. J. Hoste(Ghent University Hospital), Ravindra L. Mehta(University of California San Diego), Patrick Murray(University College Dublin), Bodil Steen Rasmussen, J. Gordon Boyd, Nicolas DeSchryver, Elisabeth Diltoer, Melanie Meersch, Bruno François(Inserm), Matthias Winkel(AM–Pharma (Netherlands)), Gordon Wood(University of Pittsburgh), Maj K. Kamper(Aalborg University), Susanne Iversen(Mahindra and Mahindra Limited (India)), Sussanne Iversen(Aarhus University Hospital), Kristie Bass(AM–Pharma (Netherlands)), U. G. Pedersen, Chistopher J. Doig(University of Calgary), Patrick M. Honoré(CHU Dinant Godinne UCL Namur), Hendrik Gammelager(Aarhus University Hospital)
Intensive Care Medicine
January 1, 2024
Cited by 67


Related Papers